Repaglinide: a new short-acting insulinotropic agent for the treatment of Type 2 diabetes.

Autor: Owens1
Zdroj: European Journal of Clinical Investigation. May1999 Supplement 2, Vol. 29, p30-37. 8p.
Databáze: Academic Search Ultimate
Externí odkaz: